In vitro synergistic interaction between DTA0100 and radiation in human cancercell lines

Anti-Cancer Agents in Medicinal Chemistry

Volumn 12, Issue 8, 2012, Pages 988-993

  Bordón, Elisa ^a   León, Leticia G ^b   Ríos Luci, Carla ^b   Lara, Pedro C ^a   Padrón, José M ^b  

^a HOSPITAL UNIVERSITARIO DE GRAN CANARIA DR NEGRÍN   (Spain)

^b UNIVERSIDAD DE LA LAGUNA   (Spain)

Author keywords

Anticancer drugs; Antiproliferative; Cancer; Catalytic inhibitor; Cell lines; Chemoradiotherapy; Chemotherapy; DNA; Drug combinations; Mechanism of action; Median drug effect; Mitosis; Radiation therapy; Screening; Topoisomerase

Indexed keywords

ANTINEOPLASTIC AGENT; DTA 0100; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL CULTURE; CELL SURVIVAL; CLINICAL PROTOCOL; COLON CANCER; CYTOTOXICITY; DRUG ANTAGONISM; DRUG EFFECT; DRUG EFFICACY; DRUG POTENTIATION; HELA CELL; HUMAN; HUMAN CELL; IN VITRO STUDY; IONIZING RADIATION; IRRADIATION; LUNG NON SMALL CELL CANCER; SOLID TUMOR; UTERINE CERVIX CANCER;

ACRYLATES; ANTINEOPLASTIC AGENTS; CAPRYLATES; CELL PROLIFERATION; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG SCREENING ASSAYS, ANTITUMOR; HELA CELLS; HUMANS; STRUCTURE-ACTIVITY RELATIONSHIP; TUMOR CELLS, CULTURED; ULTRAVIOLET RAYS;

EID: 84866413012     PISSN: 18715206     EISSN: 18755992     Source Type: Journal    
DOI: 10.2174/187152012802650057     Document Type: Article

References (20)

1. Ikushima, H. Radiation therapy: state of the art and the future. J. Med. Invest., 2010, 57, 1-11.
2. Chen, R.C.; Mamon, H.J.; Chen, Y.H.; Gelman, R.S.; Suh, W.W.; Talcott, J.A.; Clark, J.W.; Hong, T.S. Patient-reported acute gastrointestinal symptoms during concurrent chemoradiation treatment for rectal cancer. Cancer, 2010, 116, 1879-1886.
3. Teyssier, F.; Bay, J.O.; Dionet, C.; Verrelle, P. Cell cycle regulation after exposure to ionizing radiation. Bull. Cancer, 1999, 86, 345-357.
4. Howard, A.; Pelc, S.R. Synthesis of deoxyribonucleic acid in normal and irradiated cells and its relation to chromosome breakage. Int. J. Radiat. Biol., 1986, 49, 207-218.
5. Milas, L.; Milas, M.M.; Mason, K.A. Combination of taxanes with radiation: preclinical studies. Semin. Radiat. Oncol., 1999, 9, 12-26.
6. Simoens, C.; Korst, A.E.C.; De Pooter, C.M.J.; Lambrechts, H.A.; Pattyn, G.G.; Faircloth, G.T.; Lardon F, Vermorken, J.B. In vitro interaction between Ecteinascidin 743 (ET-743) and radiation, in relation to its cell cycle effects. Br. J. Cancer, 2003, 89, 2305-2311.
7. Kim, J.S.; Amorino, G.P.; Pyo, H.; Cao, Q.; Choy, H. Radiation enhancement by the combined use of topoisomerase I inhibitors, RFS-2000 or CPT-11, and topoisomerase II inhibitor etoposide in human lung cancer cells. Radiother. Oncol., 2002, 62, 61-67.
8. Chen, Y.; Lin, T.Y.; Chen, J.C.; Yang, H.Z.; Tseng, S.H. GL331, a topoisomerase II inhibitor, induces radiosensitization of human glioma cells. Anticancer Res., 2006, 26, 2149-2156.
9. Mateos, S.; Hajji, N.; Pastor, N.; Cortés, F. Modulation of radiation response by inhibiting topoisomerase II catalytic activity. Mutat. Res., 2006, 599, 105-115.
10. Sui, M.; Fan, W. Combination of gamma-radiation antagonizes the cytotoxic effects of vincristine and vinblastine on both mitotic arrest and apoptosis. Int. J. Radiat. Oncol. Biol. Phys., 2005, 61, 1151-1158.
11. Chalmers, A.J.; Ruff, E.M.; Martindale, C.; Lovegrove, N.; Short, S.C. Cytotoxic effects of temozolomide and radiation are additive-and schedule-dependent. Int. J. Radiat. Oncol. Biol. Phys., 2009, 75, 1511-1519.
12. León, L. G.; Ríos-Luci, C.; Tejedor, D.; Pérez-Roth, E.; Montero, J.C.; Pandiella, A.; García-Tellado, F.; Padrón, J.M. Mitotic arrest induced by a novel family of DNA topoisomerase II inhibitors. J. Med. Chem., 2010, 53, 3835-3839.
13. Larsen, A.K.; Escargueil, A.E.; Skladanowski, A. Catalytic topoisomerase II inhibitors in cancer therapy. Pharmacol. Ther., 2003, 99, 167-181.
14. Schilsky, R.L. Biochemical pharmacology of chemotherapeutic drugs used as radiation enhancers. Semin. Oncol., 1992, 19(Suppl. 11), 2-7.
15. Skehan, P.; Storeng, P.; Scudeiro, D.; Monks, A.; McMahon, J.; Vistica, D.; Warren, J.T.; Bokesch, H.; Kenney, S.; Boyd, M.R. New colorimetric cytotoxicity assay for anticancer-drug screening. J. Natl. Cancer Inst., 1990, 82, 1107-1112.
16. Chou, T.-C. Drug combination studies and their synergy quantification using the Chou-Talalay method. Cancer Res., 2010, 70, 440-446.
17. Chou, T.-C.; Martin, N. CompuSyn for Drug Combinations. A Computer Program for Quantitation of Synergism and Antagonism in Drug Combinations, and the Determination of IC50 and ED50 and LD50 Values [PC Software and User's Guide], ComboSyn; Paramus: NJ, 2005.
18. Shoemaker, R.H. The NCI60 human tumour cell line anticancer drug screen. Nat. Rev. Cancer, 2006, 6, 813-823.
19. Gaffney, D.K.; Lundquist, M.; Warters, R. L.; Rosley, R. Effects of modifying topoisomerase II levels on cellular recovery from radiation damage. Radiat. Res., 2000, 154, 461-466.
20. Terry, S.Y.; Riches, A.C.; Bryant, P.E. Suppression of topoisomerase IIalpha expression and function in human cells decreases chromosomal radiosensitivity. Mutat. Res., 2009, 663, 40-45.